Skip to content
Hydrotalcite
Hydrotalcite is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A02: Drugs for acid related disorders
— A02A: Antacids
— A02AD: Antacids containing combinations and complexes of aluminium, calcium and magnesium compounds
— A02AD04: Hydrotalcite
HCPCS
No data
Clinical
Clinical Trials
5 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HeartburnD006356R12———1—1
DyspepsiaD004415EFO_0008533K30———1—1
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atrophic gastritisD005757EFO_1000826K29.4————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameHYDROTALCITE
INNhydrotalcite
Description
Hydrotalcite or formerly also Völknerite is a layered double hydroxide (LDH) of general formula Mg6Al2CO3(OH)16·4H2O, whose name is derived from its resemblance with talc and its high water content. Multiple structures containing loosely bound carbonate ions exist. The easily exchanged carbonates allow for applications of the mineral in wastewater treatment and nuclear fuel reprocessing.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O.O.O.O.O=C([O-])[O-].[Al+3].[Al+3].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-]
Identifiers
PDB—
CAS-ID12304-65-3
RxCUI—
ChEMBL IDCHEMBL3833351
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID17432CG1KU (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 2,358 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
16 adverse events reported
View more details